REQUEST A DEMO
Total
USD $0.00
Search more companies

Arimed Ilac A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Arimed Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: March 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Arimed Ilac A.S. is an enterprise in Turkiye, with the main office in Istanbul. It operates in the Pharmaceutical Preparation Manufacturing industry. The enterprise was incorporated on April 01, 2013. 45 (2024) employees currently work for Arimed Ilac A.S.. In its most recent financial highlights, the company reported a net sales revenue increase of 89.41% in 2021. Over the same period, its total assets grew by 90.42%. In 2021, Arimed Ilac A.S.’s net profit margin decreased by 0.16%.

Headquarters
No:21-5 Seyrantepe Mahallesi Altinay Caddesi Kagithane
Istanbul; Marmara; Postal Code: 34418

Contact Details: Purchase the Arimed Ilac A.S. report to view the information.

Website: http://www.arimedilac.com

Basic Information
Total Employees:
Purchase the Arimed Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Arimed Ilac A.S. report to view the information.
Incorporation Date:
April 01, 2013
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Arimed Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
89.41%
Total operating revenue
89.41%
Operating profit (EBIT)
334.79%
Net Profit (Loss) for the Period
86.84%
Total assets
90.42%
Total equity
285.92%
Operating Profit Margin (ROS)
15.31%
Net Profit Margin
-0.16%
Return on Equity (ROE)
-40.91%
Quick Ratio
7.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?